RCM Technologies, Inc.

What they do

RCM Technologies provides staffing and solutions services through three segments: Engineering, Specialty HealthCare, and Information Technology. The company describes itself as serving HealthCare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions end markets. It employs billable consultants who deliver services on client engagements, and it is headquartered in Pennsauken, New Jersey.

Revenue drivers

• Engineering — Provides engineering and technical staffing to aerospace & defense, process & industrial and life sciences customers; one of the company's three reporting segments, though the excerpts do not break out segment-level revenue.
• Specialty HealthCare — Supplies healthcare staffing and related services; the 10-Q cautionary language flags risks from providing services to the healthcare industry, indicating it is a meaningful business line.
• Information Technology — Delivers IT consulting and data & solutions services; the company markets this alongside engineering and healthcare under a combined 'solutions' positioning.

Recent performance

For the fifty-three weeks ended January 3, 2026, RCM reported revenue of $319.4 million, up 14.7% from $278.4 million in the prior year, with gross profit of $87.9 million, up 10.2%. GAAP net income was $16.3 million, or $2.14 per diluted share, versus $13.3 million, or $1.68 per diluted share, a year earlier. Adjusted EBITDA was $30.7 million, up 18.9% from $25.9 million, and adjusted net income per diluted share was $2.50 versus $2.03. In the most recent quarter reported (fourteen weeks ended January 3, 2026), revenue was $86.5 million, up 12.4%, net income was $6.1 million or $0.80 per diluted share, and adjusted EBITDA rose 49.0% to $9.3 million. More recently, quarterly revenue was $93.8 million for the period ended July 4, 2026.

Strategy

The company positions itself around helping customers 'design, build, and enable the Industries of Tomorrow, Today,' with emphasis on resources, critical infrastructure and modernization of industries. It operates in HealthCare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. The 8-K disclosures since the last 10-K show a February 2026 material agreement and direct financial obligation and a May 2026 change of accountants, alongside an amended 10-K filed to supply Part III information after the company said it did not expect to file its proxy statement by May 4, 2026. No capital allocation or investment program details are provided in the excerpts.

Risks

• Government filing and reporting changes — The company changed accountants twice within roughly a year (July 2025 and May 2026) and filed a 10-K/A because it did not expect to file its proxy on time.
• Healthcare industry exposure — The 10-Q's forward-looking cautionary note specifically cites risks arising from providing services to the healthcare industry.
• Thin balance sheet relative to liabilities — At July 4, 2026, total liabilities were $85.2 million against total assets of $134.0 million and cash of just $6.6 million.
• Profitability leverage to revenue mix — Revenue grew 14.7% in fiscal 2025 while gross profit grew only 10.2%, indicating gross margin compression as revenue scales.

Outlook

The excerpts do not include management guidance for fiscal 2026 revenue or earnings, and the company stated it would not hold a conference call to discuss the fiscal 2025 results. The most recent reported quarterly revenue of $93.8 million for the period ended July 4, 2026 is the only forward datapoint available. Management's public statements point to demand for its services and pipeline as items of interest.